Gep Nets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gep nets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gep Nets Today - Breaking & Trending Today

FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs

The FDA has approved lutetium Lu 177 dotatate for pediatric patients 12 years of age and older with SSTR–positive GEP-NETs. ....

United States , Theodore Laetsch , Developmental Therapeutics Program , Gep Nets , Lutetium Lu 177 Dotatate ,

177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs

Lutetium Lu 177 dotatate plus octreotide significantly improved PFS vs high-dose octreotide in patients with gastroenteropancreatic neuroendocrine tumors. ....

Advanced Accelerator , 177lu Dotatate , Gep Nets , Gastroenteropancreatic Neuroendocrine Tumors , Neuroendocrine Tumors , Lutetium Lu 177 Dotatate , Somatostatin Analog , Phase 3 Netter 2 Trial , 2024 Gastrointestinal Cancers Symposium , Asco Gi , Simron Singh , Sunnybrook Health Sciences Centre ,

FDA Accepts Filing of Abbreviated NDA for Generic Lutathera in GEP-NETs

The FDA has accepted the filing of an abbreviated new drug application (ANDA) for Lutetium Lu 177 Dotatate, a generic version of lutetium Lu 177 dotatate indicated for the treatment of patients with somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut, and hindgut neuroendocrine tumors in adults. ....

United States , Joe Mccann , Mary Anne Heino , University Health Network , Anne Heino , Gastrointestinal Cancer , Gi Cancer , Lutetium Lu 177 Dotatate , Gep Nets , Gastroenteropancreatic Neuroendocrine Tumors ,

ITM to Present Phase III COMPOSE Poster and Host Satellite

Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the. ....

United States , Uppsala Lan , Comunidad Autonoma De Cataluna , Jaume Capdevila , Ben Orzelek , Julia Hofmann Svenja , Wolfgang Weber , Aldo Scarpa , Heloisa Soares , Uppsala University , Hospital Trust Of Verona , Hebron University Hospital , University Of Utah , European Neuroendocrine Tumor Society , Technical University Of Munich , Corporate Communications , Department Of Pathology , Oncology Department , Symposium Program , Department Of Nuclear Medicine , Division Of Oncology , Annual European Neuroendocrine Tumor Society , Therapeutics Landscape , Medical Oncology Department , Endocrine Tumor Unit , Endocrine Oncology ,